1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global JAK and PI3K Signaling Pathway Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 PI3K 1.2.3 Janus Kinase Therapies (Inhibitors) 1.2.4 PI3K Therapies (Inhibitors) 1.2.5 Signal Transduction Biomarkers for JAK and PI3K 1.3 Market by Application 1.3.1 Global JAK and PI3K Signaling Pathway Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Cancer 1.3.3 Inflammatory Diseases 1.3.4 Cardiac Ailments 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global JAK and PI3K Signaling Pathway Market Perspective (2016-2027) 2.2 JAK and PI3K Signaling Pathway Growth Trends by Regions 2.2.1 JAK and PI3K Signaling Pathway Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 JAK and PI3K Signaling Pathway Historic Market Share by Regions (2016-2021) 2.2.3 JAK and PI3K Signaling Pathway Forecasted Market Size by Regions (2022-2027) 2.3 JAK and PI3K Signaling Pathway Industry Dynamic 2.3.1 JAK and PI3K Signaling Pathway Market Trends 2.3.2 JAK and PI3K Signaling Pathway Market Drivers 2.3.3 JAK and PI3K Signaling Pathway Market Challenges 2.3.4 JAK and PI3K Signaling Pathway Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top JAK and PI3K Signaling Pathway Players by Revenue 3.1.1 Global Top JAK and PI3K Signaling Pathway Players by Revenue (2016-2021) 3.1.2 Global JAK and PI3K Signaling Pathway Revenue Market Share by Players (2016-2021) 3.2 Global JAK and PI3K Signaling Pathway Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by JAK and PI3K Signaling Pathway Revenue 3.4 Global JAK and PI3K Signaling Pathway Market Concentration Ratio 3.4.1 Global JAK and PI3K Signaling Pathway Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by JAK and PI3K Signaling Pathway Revenue in 2020 3.5 JAK and PI3K Signaling Pathway Key Players Head office and Area Served 3.6 Key Players JAK and PI3K Signaling Pathway Product Solution and Service 3.7 Date of Enter into JAK and PI3K Signaling Pathway Market 3.8 Mergers & Acquisitions, Expansion Plans 4 JAK and PI3K Signaling Pathway Breakdown Data by Type 4.1 Global JAK and PI3K Signaling Pathway Historic Market Size by Type (2016-2021) 4.2 Global JAK and PI3K Signaling Pathway Forecasted Market Size by Type (2022-2027) 5 JAK and PI3K Signaling Pathway Breakdown Data by Application 5.1 Global JAK and PI3K Signaling Pathway Historic Market Size by Application (2016-2021) 5.2 Global JAK and PI3K Signaling Pathway Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America JAK and PI3K Signaling Pathway Market Size (2016-2027) 6.2 North America JAK and PI3K Signaling Pathway Market Size by Type 6.2.1 North America JAK and PI3K Signaling Pathway Market Size by Type (2016-2021) 6.2.2 North America JAK and PI3K Signaling Pathway Market Size by Type (2022-2027) 6.2.3 North America JAK and PI3K Signaling Pathway Market Size by Type (2016-2027) 6.3 North America JAK and PI3K Signaling Pathway Market Size by Application 6.3.1 North America JAK and PI3K Signaling Pathway Market Size by Application (2016-2021) 6.3.2 North America JAK and PI3K Signaling Pathway Market Size by Application (2022-2027) 6.3.3 North America JAK and PI3K Signaling Pathway Market Size by Application (2016-2027) 6.4 North America JAK and PI3K Signaling Pathway Market Size by Country 6.4.1 North America JAK and PI3K Signaling Pathway Market Size by Country (2016-2021) 6.4.2 North America JAK and PI3K Signaling Pathway Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe JAK and PI3K Signaling Pathway Market Size (2016-2027) 7.2 Europe JAK and PI3K Signaling Pathway Market Size by Type 7.2.1 Europe JAK and PI3K Signaling Pathway Market Size by Type (2016-2021) 7.2.2 Europe JAK and PI3K Signaling Pathway Market Size by Type (2022-2027) 7.2.3 Europe JAK and PI3K Signaling Pathway Market Size by Type (2016-2027) 7.3 Europe JAK and PI3K Signaling Pathway Market Size by Application 7.3.1 Europe JAK and PI3K Signaling Pathway Market Size by Application (2016-2021) 7.3.2 Europe JAK and PI3K Signaling Pathway Market Size by Application (2022-2027) 7.3.3 Europe JAK and PI3K Signaling Pathway Market Size by Application (2016-2027) 7.4 Europe JAK and PI3K Signaling Pathway Market Size by Country 7.4.1 Europe JAK and PI3K Signaling Pathway Market Size by Country (2016-2021) 7.4.2 Europe JAK and PI3K Signaling Pathway Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific JAK and PI3K Signaling Pathway Market Size (2016-2027) 8.2 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Type 8.2.1 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Type (2016-2021) 8.2.2 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Type (2022-2027) 8.2.3 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Type (2016-2027) 8.3 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Application 8.3.1 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Application (2016-2021) 8.3.2 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Application (2022-2027) 8.3.3 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Application (2016-2027) 8.4 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Region 8.4.1 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Region (2016-2021) 8.4.2 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America JAK and PI3K Signaling Pathway Market Size (2016-2027) 9.2 Latin America JAK and PI3K Signaling Pathway Market Size by Type 9.2.1 Latin America JAK and PI3K Signaling Pathway Market Size by Type (2016-2021) 9.2.2 Latin America JAK and PI3K Signaling Pathway Market Size by Type (2022-2027) 9.2.3 Latin America JAK and PI3K Signaling Pathway Market Size by Type (2016-2027) 9.3 Latin America JAK and PI3K Signaling Pathway Market Size by Application 9.3.1 Latin America JAK and PI3K Signaling Pathway Market Size by Application (2016-2021) 9.3.2 Latin America JAK and PI3K Signaling Pathway Market Size by Application (2022-2027) 9.3.3 Latin America JAK and PI3K Signaling Pathway Market Size by Application (2016-2027) 9.4 Latin America JAK and PI3K Signaling Pathway Market Size by Country 9.4.1 Latin America JAK and PI3K Signaling Pathway Market Size by Country (2016-2021) 9.4.2 Latin America JAK and PI3K Signaling Pathway Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa JAK and PI3K Signaling Pathway Market Size (2016-2027) 10.2 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Type 10.2.1 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Type (2016-2021) 10.2.2 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Type (2022-2027) 10.2.3 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Type (2016-2027) 10.3 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Application 10.3.1 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Application (2016-2021) 10.3.2 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Application (2022-2027) 10.3.3 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Application (2016-2027) 10.4 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Country 10.4.1 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Country (2016-2021) 10.4.2 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Bayer HealthCare Pharmaceuticals 11.1.1 Bayer HealthCare Pharmaceuticals Company Details 11.1.2 Bayer HealthCare Pharmaceuticals Business Overview 11.1.3 Bayer HealthCare Pharmaceuticals JAK and PI3K Signaling Pathway Introduction 11.1.4 Bayer HealthCare Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) 11.1.5 Bayer HealthCare Pharmaceuticals Recent Development 11.2 AbbVie 11.2.1 AbbVie Company Details 11.2.2 AbbVie Business Overview 11.2.3 AbbVie JAK and PI3K Signaling Pathway Introduction 11.2.4 AbbVie Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) 11.2.5 AbbVie Recent Development 11.3 AstraZeneca 11.3.1 AstraZeneca Company Details 11.3.2 AstraZeneca Business Overview 11.3.3 AstraZeneca JAK and PI3K Signaling Pathway Introduction 11.3.4 AstraZeneca Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) 11.3.5 AstraZeneca Recent Development 11.4 Curis 11.4.1 Curis Company Details 11.4.2 Curis Business Overview 11.4.3 Curis JAK and PI3K Signaling Pathway Introduction 11.4.4 Curis Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) 11.4.5 Curis Recent Development 11.5 Daiichi Sankyo 11.5.1 Daiichi Sankyo Company Details 11.5.2 Daiichi Sankyo Business Overview 11.5.3 Daiichi Sankyo JAK and PI3K Signaling Pathway Introduction 11.5.4 Daiichi Sankyo Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) 11.5.5 Daiichi Sankyo Recent Development 11.6 Exelixis 11.6.1 Exelixis Company Details 11.6.2 Exelixis Business Overview 11.6.3 Exelixis JAK and PI3K Signaling Pathway Introduction 11.6.4 Exelixis Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) 11.6.5 Exelixis Recent Development 11.7 Genentech 11.7.1 Genentech Company Details 11.7.2 Genentech Business Overview 11.7.3 Genentech JAK and PI3K Signaling Pathway Introduction 11.7.4 Genentech Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) 11.7.5 Genentech Recent Development 11.8 Infinity Pharmaceuticals 11.8.1 Infinity Pharmaceuticals Company Details 11.8.2 Infinity Pharmaceuticals Business Overview 11.8.3 Infinity Pharmaceuticals JAK and PI3K Signaling Pathway Introduction 11.8.4 Infinity Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) 11.8.5 Infinity Pharmaceuticals Recent Development 11.9 Merck & Co. 11.9.1 Merck & Co. Company Details 11.9.2 Merck & Co. Business Overview 11.9.3 Merck & Co. JAK and PI3K Signaling Pathway Introduction 11.9.4 Merck & Co. Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) 11.9.5 Merck & Co. Recent Development 11.10 Rigel Pharmaceuticals 11.10.1 Rigel Pharmaceuticals Company Details 11.10.2 Rigel Pharmaceuticals Business Overview 11.10.3 Rigel Pharmaceuticals JAK and PI3K Signaling Pathway Introduction 11.10.4 Rigel Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) 11.10.5 Rigel Pharmaceuticals Recent Development 11.11 TG Therapeutics 11.11.1 TG Therapeutics Company Details 11.11.2 TG Therapeutics Business Overview 11.11.3 TG Therapeutics JAK and PI3K Signaling Pathway Introduction 11.11.4 TG Therapeutics Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) 11.11.5 TG Therapeutics Recent Development 11.12 Sanofi Oncology 11.12.1 Sanofi Oncology Company Details 11.12.2 Sanofi Oncology Business Overview 11.12.3 Sanofi Oncology JAK and PI3K Signaling Pathway Introduction 11.12.4 Sanofi Oncology Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) 11.12.5 Sanofi Oncology Recent Development 11.13 Vertex Pharmaceuticals 11.13.1 Vertex Pharmaceuticals Company Details 11.13.2 Vertex Pharmaceuticals Business Overview 11.13.3 Vertex Pharmaceuticals JAK and PI3K Signaling Pathway Introduction 11.13.4 Vertex Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) 11.13.5 Vertex Pharmaceuticals Recent Development 11.14 WILEX AG 11.14.1 WILEX AG Company Details 11.14.2 WILEX AG Business Overview 11.14.3 WILEX AG JAK and PI3K Signaling Pathway Introduction 11.14.4 WILEX AG Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) 11.14.5 WILEX AG Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global JAK and PI3K Signaling Pathway Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of PI3K Table 3. Key Players of Janus Kinase Therapies (Inhibitors) Table 4. Key Players of PI3K Therapies (Inhibitors) Table 5. Key Players of Signal Transduction Biomarkers for JAK and PI3K Table 6. Global JAK and PI3K Signaling Pathway Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global JAK and PI3K Signaling Pathway Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global JAK and PI3K Signaling Pathway Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global JAK and PI3K Signaling Pathway Market Share by Regions (2016-2021) Table 10. Global JAK and PI3K Signaling Pathway Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global JAK and PI3K Signaling Pathway Market Share by Regions (2022-2027) Table 12. JAK and PI3K Signaling Pathway Market Trends Table 13. JAK and PI3K Signaling Pathway Market Drivers Table 14. JAK and PI3K Signaling Pathway Market Challenges Table 15. JAK and PI3K Signaling Pathway Market Restraints Table 16. Global JAK and PI3K Signaling Pathway Revenue by Players (2016-2021) & (US$ Million) Table 17. Global JAK and PI3K Signaling Pathway Market Share by Players (2016-2021) Table 18. Global Top JAK and PI3K Signaling Pathway Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in JAK and PI3K Signaling Pathway as of 2020) Table 19. Ranking of Global Top JAK and PI3K Signaling Pathway Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by JAK and PI3K Signaling Pathway Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players JAK and PI3K Signaling Pathway Product Solution and Service Table 23. Date of Enter into JAK and PI3K Signaling Pathway Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global JAK and PI3K Signaling Pathway Market Size by Type (2016-2021) (US$ Million) Table 26. Global JAK and PI3K Signaling Pathway Revenue Market Share by Type (2016-2021) Table 27. Global JAK and PI3K Signaling Pathway Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global JAK and PI3K Signaling Pathway Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global JAK and PI3K Signaling Pathway Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global JAK and PI3K Signaling Pathway Revenue Market Share by Application (2016-2021) Table 31. Global JAK and PI3K Signaling Pathway Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global JAK and PI3K Signaling Pathway Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America JAK and PI3K Signaling Pathway Market Size by Type (2016-2021) (US$ Million) Table 34. North America JAK and PI3K Signaling Pathway Market Size by Type (2022-2027) & (US$ Million) Table 35. North America JAK and PI3K Signaling Pathway Market Size by Application (2016-2021) (US$ Million) Table 36. North America JAK and PI3K Signaling Pathway Market Size by Application (2022-2027) & (US$ Million) Table 37. North America JAK and PI3K Signaling Pathway Market Size by Country (2016-2021) & (US$ Million) Table 38. North America JAK and PI3K Signaling Pathway Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe JAK and PI3K Signaling Pathway Market Size by Type (2016-2021) (US$ Million) Table 40. Europe JAK and PI3K Signaling Pathway Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe JAK and PI3K Signaling Pathway Market Size by Application (2016-2021) (US$ Million) Table 42. Europe JAK and PI3K Signaling Pathway Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe JAK and PI3K Signaling Pathway Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe JAK and PI3K Signaling Pathway Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America JAK and PI3K Signaling Pathway Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America JAK and PI3K Signaling Pathway Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America JAK and PI3K Signaling Pathway Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America JAK and PI3K Signaling Pathway Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America JAK and PI3K Signaling Pathway Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America JAK and PI3K Signaling Pathway Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Country (2022-2027) & (US$ Million) Table 63. Bayer HealthCare Pharmaceuticals Company Details Table 64. Bayer HealthCare Pharmaceuticals Business Overview Table 65. Bayer HealthCare Pharmaceuticals JAK and PI3K Signaling Pathway Product Table 66. Bayer HealthCare Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million) Table 67. Bayer HealthCare Pharmaceuticals Recent Development Table 68. AbbVie Company Details Table 69. AbbVie Business Overview Table 70. AbbVie JAK and PI3K Signaling Pathway Product Table 71. AbbVie Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million) Table 72. AbbVie Recent Development Table 73. AstraZeneca Company Details Table 74. AstraZeneca Business Overview Table 75. AstraZeneca JAK and PI3K Signaling Pathway Product Table 76. AstraZeneca Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million) Table 77. AstraZeneca Recent Development Table 78. Curis Company Details Table 79. Curis Business Overview Table 80. Curis JAK and PI3K Signaling Pathway Product Table 81. Curis Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million) Table 82. Curis Recent Development Table 83. Daiichi Sankyo Company Details Table 84. Daiichi Sankyo Business Overview Table 85. Daiichi Sankyo JAK and PI3K Signaling Pathway Product Table 86. Daiichi Sankyo Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million) Table 87. Daiichi Sankyo Recent Development Table 88. Exelixis Company Details Table 89. Exelixis Business Overview Table 90. Exelixis JAK and PI3K Signaling Pathway Product Table 91. Exelixis Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million) Table 92. Exelixis Recent Development Table 93. Genentech Company Details Table 94. Genentech Business Overview Table 95. Genentech JAK and PI3K Signaling Pathway Product Table 96. Genentech Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million) Table 97. Genentech Recent Development Table 98. Infinity Pharmaceuticals Company Details Table 99. Infinity Pharmaceuticals Business Overview Table 100. Infinity Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million) Table 101. Infinity Pharmaceuticals Recent Development Table 102. Merck & Co. Company Details Table 103. Merck & Co. Business Overview Table 104. Merck & Co. JAK and PI3K Signaling Pathway Product Table 105. Merck & Co. Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million) Table 106. Merck & Co. Recent Development Table 107. Rigel Pharmaceuticals Company Details Table 108. Rigel Pharmaceuticals Business Overview Table 109. Rigel Pharmaceuticals JAK and PI3K Signaling Pathway Product Table 110. Rigel Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million) Table 111. Rigel Pharmaceuticals Recent Development Table 112. TG Therapeutics Company Details Table 113. TG Therapeutics Business Overview Table 114. TG Therapeutics JAK and PI3K Signaling Pathway Product Table 115. TG Therapeutics Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million) Table 116. TG Therapeutics Recent Development Table 117. Sanofi Oncology Company Details Table 118. Sanofi Oncology Business Overview Table 119. Sanofi Oncology JAK and PI3K Signaling Pathway Product Table 120. Sanofi Oncology Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million) Table 121. Sanofi Oncology Recent Development Table 122. Vertex Pharmaceuticals Company Details Table 123. Vertex Pharmaceuticals Business Overview Table 124. Vertex Pharmaceuticals JAK and PI3K Signaling Pathway Product Table 125. Vertex Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million) Table 126. Vertex Pharmaceuticals Recent Development Table 127. WILEX AG Company Details Table 128. WILEX AG Business Overview Table 129. WILEX AG JAK and PI3K Signaling Pathway Product Table 130. WILEX AG Revenue in JAK and PI3K Signaling Pathway Business (2016-2021) & (US$ Million) Table 131. WILEX AG Recent Development Table 132. Research Programs/Design for This Report Table 133. Key Data Information from Secondary Sources Table 134. Key Data Information from Primary Sources List of Figures Figure 1. Global JAK and PI3K Signaling Pathway Market Share by Type: 2020 VS 2027 Figure 2. PI3K Features Figure 3. Janus Kinase Therapies (Inhibitors) Features Figure 4. PI3K Therapies (Inhibitors) Features Figure 5. Signal Transduction Biomarkers for JAK and PI3K Features Figure 6. Global JAK and PI3K Signaling Pathway Market Share by Application: 2020 VS 2027 Figure 7. Cancer Case Studies Figure 8. Inflammatory Diseases Case Studies Figure 9. Cardiac Ailments Case Studies Figure 10. Others Case Studies Figure 11. JAK and PI3K Signaling Pathway Report Years Considered Figure 12. Global JAK and PI3K Signaling Pathway Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global JAK and PI3K Signaling Pathway Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global JAK and PI3K Signaling Pathway Market Share by Regions: 2020 VS 2027 Figure 15. Global JAK and PI3K Signaling Pathway Market Share by Regions (2022-2027) Figure 16. Global JAK and PI3K Signaling Pathway Market Share by Players in 2020 Figure 17. Global Top JAK and PI3K Signaling Pathway Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in JAK and PI3K Signaling Pathway as of 2020 Figure 18. The Top 10 and 5 Players Market Share by JAK and PI3K Signaling Pathway Revenue in 2020 Figure 19. Global JAK and PI3K Signaling Pathway Revenue Market Share by Type (2016-2021) Figure 20. Global JAK and PI3K Signaling Pathway Revenue Market Share by Type (2022-2027) Figure 21. North America JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America JAK and PI3K Signaling Pathway Market Share by Type (2016-2027) Figure 23. North America JAK and PI3K Signaling Pathway Market Share by Application (2016-2027) Figure 24. North America JAK and PI3K Signaling Pathway Market Share by Country (2016-2027) Figure 25. United States JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe JAK and PI3K Signaling Pathway Market Share by Type (2016-2027) Figure 29. Europe JAK and PI3K Signaling Pathway Market Share by Application (2016-2027) Figure 30. Europe JAK and PI3K Signaling Pathway Market Share by Country (2016-2027) Figure 31. Germany JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific JAK and PI3K Signaling Pathway Market Share by Type (2016-2027) Figure 39. Asia-Pacific JAK and PI3K Signaling Pathway Market Share by Application (2016-2027) Figure 40. Asia-Pacific JAK and PI3K Signaling Pathway Market Share by Region (2016-2027) Figure 41. China JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America JAK and PI3K Signaling Pathway Market Share by Type (2016-2027) Figure 49. Latin America JAK and PI3K Signaling Pathway Market Share by Application (2016-2027) Figure 50. Latin America JAK and PI3K Signaling Pathway Market Share by Country (2016-2027) Figure 51. Mexico JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa JAK and PI3K Signaling Pathway Market Share by Type (2016-2027) Figure 55. Middle East & Africa JAK and PI3K Signaling Pathway Market Share by Application (2016-2027) Figure 56. Middle East & Africa JAK and PI3K Signaling Pathway Market Share by Country (2016-2027) Figure 57. Turkey JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE JAK and PI3K Signaling Pathway Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Bayer HealthCare Pharmaceuticals Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021) Figure 61. AbbVie Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021) Figure 62. AstraZeneca Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021) Figure 63. Curis Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021) Figure 64. Daiichi Sankyo Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021) Figure 65. Exelixis Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021) Figure 66. Genentech Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021) Figure 67. Infinity Pharmaceuticals Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021) Figure 68. Merck & Co. Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021) Figure 69. Rigel Pharmaceuticals Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021) Figure 70. TG Therapeutics Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021) Figure 71. Sanofi Oncology Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021) Figure 72. Vertex Pharmaceuticals Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021) Figure 73. WILEX AG Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2016-2021) Figure 74. Bottom-up and Top-down Approaches for This Report Figure 75. Data Triangulation Figure 76. Key Executives Interviewed

Bayer HealthCare Pharmaceuticals AbbVie AstraZeneca Curis Daiichi Sankyo Exelixis Genentech Infinity Pharmaceuticals Merck & Co. Rigel Pharmaceuticals TG Therapeutics Sanofi Oncology Vertex Pharmaceuticals WILEX AG